ACS To open Key Positions To Competition In Massive “Reorganization for the ‘90’s
In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia
New ACS Structure Proposed, approved
Seffrin; First Year ACS Shows “Simple Problems Aren’t”
Diet Supplements Should Be Held To Scientific Standards, Broder Tells House
NCI Awards Regional CIS Contracts
FDA Encourages Study Of Gender Differences
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded” - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel
